Filing Details

Accession Number:
0001225208-12-006943
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-03-06 19:29:03
Reporting Period:
2012-03-02
Filing Date:
2012-03-06
Accepted Time:
2012-03-06 19:29:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1492426 Horizon Pharma Inc. HZNP Pharmaceutical Preparations (2834) 272179987
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1250409 W Jeffrey Bird 755 Page Mill Road, Suite A-200
Palo Alto CA 94304-1005
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-03-02 5,000 $3.59 5,000 No 4 P Indirect By Individual ROTH IRA
Common Stock Acquisiton 2012-03-02 7,000 $3.59 7,000 No 4 P Indirect By Ltd Partnership (NEST)
Common Stock Acquisiton 2012-03-02 645,820 $3.59 1,609,980 No 4 P Indirect By Ltd Partnership (SHV)
Common Stock Acquisiton 2012-03-02 22,473 $3.59 59,035 No 4 P Indirect By Trust (Trustees)
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Individual ROTH IRA
No 4 P Indirect By Ltd Partnership (NEST)
No 4 P Indirect By Ltd Partnership (SHV)
No 4 P Indirect By Trust (Trustees)
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant to Purchase Common Stock Acquisiton 2012-03-02 1,250 $0.03 1,250 $4.31
Common Stock Warrant to Purchase Common Stock Acquisiton 2012-03-02 1,750 $0.03 1,750 $4.31
Common Stock Warrant to Purchase Common Stock Acquisiton 2012-03-02 161,455 $0.03 161,455 $4.31
Common Stock Warrant to Purchase Common Stock Acquisiton 2012-03-02 5,618 $0.03 5,618 $4.31
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,250 2012-03-02 2017-03-02 No 4 P Indirect
1,750 2012-03-02 2017-03-02 No 4 P Indirect
161,455 2012-03-02 2017-03-02 No 4 P Indirect
5,618 2012-03-02 2017-03-02 No 4 P Indirect
Footnotes
  1. Acquired from the issuer pursuant to a Securities Purchase Agreement dated February 28, 2012, with a closing date of March 2, 2012.
  2. Shares held by an individual retirement account, for the benefit of the reporting person.
  3. Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the General Partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
  4. Shares held by Sutter Hill Ventures, A California Limited Partnership. The reporting person is a Managing Director of the General Partner of Sutter Hill Ventures, A California Limited Partnership. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
  5. Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
  6. Full amount of Warrant Purchase Price is $0.03125